Walden University NURS 6521 Fall 2026
Comprehensive Final Practice Questions (docx) |
2026/2027 | Advanced Pharmacology Q&A | Nursing
1. During oral drug administration, what does first-pass metabolism primarily reduce?
A) Systemic bioavailability of susceptible drugs
B) Renal filtration of unchanged drug
C) Affinity at the target receptor
D) Plasma protein synthesis
Correct Answer: Systemic bioavailability of susceptible drugs
Rationale: Presystemic intestinal and hepatic metabolism can remove drug before it reaches systemic
circulation. Intravenous delivery bypasses this process. The extent differs across drugs and patients. The
specific drug and patient context determine how this principle should be applied in a safe prescribing plan with
attention to individual risk factors, medication history, practical monitoring needs, and timely reassessment of
therapeutic response.
2. A medication has a narrow therapeutic index. Which prescribing safeguard is most relevant?
A) Automatically double the loading dose
B) Monitor drug concentrations or validated clinical markers when indicated
C) Avoid reviewing interacting medications
D) Assume adverse effects are unrelated to concentration
Correct Answer: Monitor drug concentrations or validated clinical markers when indicated
Rationale: Small differences between effective and toxic exposure make monitoring especially important. Drug
levels are useful for selected agents rather than every medication. Renal function, interactions, and clinical
response also guide dosing. The specific drug and patient context determine how this principle should be
applied in a safe prescribing plan with attention to individual risk factors, medication history, practical
monitoring needs, and timely reassessment of therapeutic response.
3. For a drug cleared mainly by the kidneys, declining glomerular filtration generally calls for which action?
A) Increase every maintenance dose
B) Discontinue all medications immediately
C) Reassess maintenance dose or dosing interval
D) Assume oral absorption has stopped
Correct Answer: Reassess maintenance dose or dosing interval
Rationale: Reduced renal clearance can prolong half-life and cause accumulation. The correct adjustment
depends on the agent, indication, and estimated renal function. Some drugs require avoidance rather than
simple dose reduction. The specific drug and patient context determine how this principle should be applied in a
,safe prescribing plan with attention to individual risk factors, medication history, practical monitoring needs,
and timely reassessment of therapeutic response.
4. An enzyme inhibitor is added to a regimen containing a CYP-metabolized drug. What outcome is possible?
A) Guaranteed reduced drug absorption
B) Immediate loss of all receptor activity
C) Elimination of pharmacodynamic interactions
D) Increased exposure to the substrate drug
Correct Answer: Increased exposure to the substrate drug
Rationale: Enzyme inhibition can slow substrate metabolism and increase exposure. Clinical importance
depends on the specific enzyme and drug. Medication reconciliation helps identify combinations that require
monitoring or an alternative. The specific drug and patient context determine how this principle should be
applied in a safe prescribing plan with attention to individual risk factors, medication history, practical
monitoring needs, and timely reassessment of therapeutic response.
5. When a partial agonist competes with a full agonist at the same receptor, what may occur?
A) A lower maximal receptor response
B) Irreversible destruction of the receptor
C) A higher response than every full agonist
D) Complete absence of receptor binding
Correct Answer: A lower maximal receptor response
Rationale: Partial agonists have intrinsic activity but a lower maximal effect than full agonists. Competition can
reduce the response to a full agonist. The result depends on receptor occupancy and the clinical context. The
specific drug and patient context determine how this principle should be applied in a safe prescribing plan.
6. A genotype predicts poor metabolism of a prodrug requiring CYP activation. Which concern is most relevant?
A) Uniformly increased activation of the prodrug
B) Reduced formation of the active metabolite
C) Elimination of all drug interactions
D) Increased renal synthesis of the drug
Correct Answer: Reduced formation of the active metabolite
Rationale: Some prodrugs require enzyme-mediated conversion to become active. Poor metabolizer status can
reduce efficacy for those agents. Genotype-guided decisions must be specific to the drug and supported by
evidence. The specific drug and patient context determine how this principle should be applied in a safe
prescribing plan with attention to individual risk factors, medication history, practical monitoring needs, and
timely reassessment of therapeutic response.
7. Before prescribing a new medication to an older adult taking eight drugs, which step most directly reduces
preventable harm?
,A) Assume nonprescription products are harmless
B) Stop every existing medicine without review
C) Reconcile all prescribed, over-the-counter, and herbal products
D) Use the highest adult starting dose
Correct Answer: Reconcile all prescribed, over-the-counter, and herbal products
Rationale: Complete reconciliation reveals duplicate therapy, interactions, and adherence barriers. Age-related
physiologic changes can alter drug handling. A focused indication and monitoring plan improves prescribing
safety. The specific drug and patient context determine how this principle should be applied in a safe
prescribing plan with attention to individual risk factors, medication history, practical monitoring needs, and
timely reassessment of therapeutic response.
8. A sustained-release tablet is labeled do not crush. What is the main reason?
A) Crushing reliably improves controlled delivery
B) Crushing prevents gastrointestinal absorption
C) The coating is always an antibiotic
D) Crushing may release the dose too rapidly
Correct Answer: Crushing may release the dose too rapidly
Rationale: Altering some modified-release products defeats their delivery mechanism. Dose dumping can
increase toxicity and shorten duration. A suitable liquid or immediate-release alternative may be needed when
swallowing is difficult. The specific drug and patient context determine how this principle should be applied in a
safe prescribing plan with attention to individual risk factors, medication history, practical monitoring needs,
and timely reassessment of therapeutic response.
9. A prescriber discovers a clinically significant medication error. Which immediate priority is appropriate?
A) Assess and protect the patient, then follow disclosure and reporting requirements
B) Alter the chart to conceal the error
C) Wait until the next annual review
D) Assume the pharmacist bears sole responsibility
Correct Answer: Assess and protect the patient, then follow disclosure and reporting requirements
Rationale: Patient assessment and mitigation of harm come first. Transparent communication and accurate
documentation support safe follow-up. Reporting and disclosure should follow applicable institutional and
jurisdictional requirements. The specific drug and patient context determine how this principle should be
applied in a safe prescribing plan with attention to individual risk factors, medication history, practical
monitoring needs, and timely reassessment of therapeutic response.
10. When selecting a first-line treatment, which approach best represents evidence-based prescribing?
A) Choose only the newest marketed drug
B) Integrate evidence, patient characteristics, preferences, and affordability
, C) Ignore contraindications when efficacy is high
D) Use the same regimen regardless of comorbidity
Correct Answer: Integrate evidence, patient characteristics, preferences, and affordability
Rationale: Evidence-based prescribing combines clinical evidence with individual risks and goals. Affordability
and treatment burden affect adherence. Reassessment is needed when response or circumstances change.
The specific drug and patient context determine how this principle should be applied in a safe prescribing plan
with attention to individual risk factors, medication history, practical monitoring needs, and timely
reassessment of therapeutic response.
11. An adult develops a persistent dry cough after starting lisinopril. Which class is commonly considered as an
alternative?
A) Another ACE inhibitor at twice the dose
B) Direct thrombin inhibitor
C) Angiotensin receptor blocker
D) Class I antiarrhythmic
Correct Answer: Angiotensin receptor blocker
Rationale: ACE inhibitors can increase bradykinin and provoke cough. ARBs block angiotensin II receptors
without the same bradykinin effect. Prior angioedema requires careful individualized assessment. Treatment
decisions should also reflect comorbidities, current guidelines, and ongoing assessment of clinical response
and adverse effects with attention to individual risk factors, medication history, practical monitoring needs, and
timely reassessment of therapeutic response.
12. For a patient prescribed spironolactone, which laboratory value deserves particular surveillance?
A) Serum amylase alone
B) Platelet count only
C) Serum uric acid only
D) Serum potassium
Correct Answer: Serum potassium
Rationale: Mineralocorticoid receptor antagonists reduce potassium excretion and may cause hyperkalemia.
Renal function also affects risk. Baseline and follow-up monitoring guide safe use. Treatment decisions should
also reflect comorbidities, current guidelines, and ongoing assessment of clinical response and adverse effects
with attention to individual risk factors, medication history, practical monitoring needs, and timely
reassessment of therapeutic response.
13. In symptomatic heart failure with reduced ejection fraction, which drug class has evidence for reducing
hospitalization and mortality?
A) SGLT2 inhibitors
B) Short-acting nitrates alone
Comprehensive Final Practice Questions (docx) |
2026/2027 | Advanced Pharmacology Q&A | Nursing
1. During oral drug administration, what does first-pass metabolism primarily reduce?
A) Systemic bioavailability of susceptible drugs
B) Renal filtration of unchanged drug
C) Affinity at the target receptor
D) Plasma protein synthesis
Correct Answer: Systemic bioavailability of susceptible drugs
Rationale: Presystemic intestinal and hepatic metabolism can remove drug before it reaches systemic
circulation. Intravenous delivery bypasses this process. The extent differs across drugs and patients. The
specific drug and patient context determine how this principle should be applied in a safe prescribing plan with
attention to individual risk factors, medication history, practical monitoring needs, and timely reassessment of
therapeutic response.
2. A medication has a narrow therapeutic index. Which prescribing safeguard is most relevant?
A) Automatically double the loading dose
B) Monitor drug concentrations or validated clinical markers when indicated
C) Avoid reviewing interacting medications
D) Assume adverse effects are unrelated to concentration
Correct Answer: Monitor drug concentrations or validated clinical markers when indicated
Rationale: Small differences between effective and toxic exposure make monitoring especially important. Drug
levels are useful for selected agents rather than every medication. Renal function, interactions, and clinical
response also guide dosing. The specific drug and patient context determine how this principle should be
applied in a safe prescribing plan with attention to individual risk factors, medication history, practical
monitoring needs, and timely reassessment of therapeutic response.
3. For a drug cleared mainly by the kidneys, declining glomerular filtration generally calls for which action?
A) Increase every maintenance dose
B) Discontinue all medications immediately
C) Reassess maintenance dose or dosing interval
D) Assume oral absorption has stopped
Correct Answer: Reassess maintenance dose or dosing interval
Rationale: Reduced renal clearance can prolong half-life and cause accumulation. The correct adjustment
depends on the agent, indication, and estimated renal function. Some drugs require avoidance rather than
simple dose reduction. The specific drug and patient context determine how this principle should be applied in a
,safe prescribing plan with attention to individual risk factors, medication history, practical monitoring needs,
and timely reassessment of therapeutic response.
4. An enzyme inhibitor is added to a regimen containing a CYP-metabolized drug. What outcome is possible?
A) Guaranteed reduced drug absorption
B) Immediate loss of all receptor activity
C) Elimination of pharmacodynamic interactions
D) Increased exposure to the substrate drug
Correct Answer: Increased exposure to the substrate drug
Rationale: Enzyme inhibition can slow substrate metabolism and increase exposure. Clinical importance
depends on the specific enzyme and drug. Medication reconciliation helps identify combinations that require
monitoring or an alternative. The specific drug and patient context determine how this principle should be
applied in a safe prescribing plan with attention to individual risk factors, medication history, practical
monitoring needs, and timely reassessment of therapeutic response.
5. When a partial agonist competes with a full agonist at the same receptor, what may occur?
A) A lower maximal receptor response
B) Irreversible destruction of the receptor
C) A higher response than every full agonist
D) Complete absence of receptor binding
Correct Answer: A lower maximal receptor response
Rationale: Partial agonists have intrinsic activity but a lower maximal effect than full agonists. Competition can
reduce the response to a full agonist. The result depends on receptor occupancy and the clinical context. The
specific drug and patient context determine how this principle should be applied in a safe prescribing plan.
6. A genotype predicts poor metabolism of a prodrug requiring CYP activation. Which concern is most relevant?
A) Uniformly increased activation of the prodrug
B) Reduced formation of the active metabolite
C) Elimination of all drug interactions
D) Increased renal synthesis of the drug
Correct Answer: Reduced formation of the active metabolite
Rationale: Some prodrugs require enzyme-mediated conversion to become active. Poor metabolizer status can
reduce efficacy for those agents. Genotype-guided decisions must be specific to the drug and supported by
evidence. The specific drug and patient context determine how this principle should be applied in a safe
prescribing plan with attention to individual risk factors, medication history, practical monitoring needs, and
timely reassessment of therapeutic response.
7. Before prescribing a new medication to an older adult taking eight drugs, which step most directly reduces
preventable harm?
,A) Assume nonprescription products are harmless
B) Stop every existing medicine without review
C) Reconcile all prescribed, over-the-counter, and herbal products
D) Use the highest adult starting dose
Correct Answer: Reconcile all prescribed, over-the-counter, and herbal products
Rationale: Complete reconciliation reveals duplicate therapy, interactions, and adherence barriers. Age-related
physiologic changes can alter drug handling. A focused indication and monitoring plan improves prescribing
safety. The specific drug and patient context determine how this principle should be applied in a safe
prescribing plan with attention to individual risk factors, medication history, practical monitoring needs, and
timely reassessment of therapeutic response.
8. A sustained-release tablet is labeled do not crush. What is the main reason?
A) Crushing reliably improves controlled delivery
B) Crushing prevents gastrointestinal absorption
C) The coating is always an antibiotic
D) Crushing may release the dose too rapidly
Correct Answer: Crushing may release the dose too rapidly
Rationale: Altering some modified-release products defeats their delivery mechanism. Dose dumping can
increase toxicity and shorten duration. A suitable liquid or immediate-release alternative may be needed when
swallowing is difficult. The specific drug and patient context determine how this principle should be applied in a
safe prescribing plan with attention to individual risk factors, medication history, practical monitoring needs,
and timely reassessment of therapeutic response.
9. A prescriber discovers a clinically significant medication error. Which immediate priority is appropriate?
A) Assess and protect the patient, then follow disclosure and reporting requirements
B) Alter the chart to conceal the error
C) Wait until the next annual review
D) Assume the pharmacist bears sole responsibility
Correct Answer: Assess and protect the patient, then follow disclosure and reporting requirements
Rationale: Patient assessment and mitigation of harm come first. Transparent communication and accurate
documentation support safe follow-up. Reporting and disclosure should follow applicable institutional and
jurisdictional requirements. The specific drug and patient context determine how this principle should be
applied in a safe prescribing plan with attention to individual risk factors, medication history, practical
monitoring needs, and timely reassessment of therapeutic response.
10. When selecting a first-line treatment, which approach best represents evidence-based prescribing?
A) Choose only the newest marketed drug
B) Integrate evidence, patient characteristics, preferences, and affordability
, C) Ignore contraindications when efficacy is high
D) Use the same regimen regardless of comorbidity
Correct Answer: Integrate evidence, patient characteristics, preferences, and affordability
Rationale: Evidence-based prescribing combines clinical evidence with individual risks and goals. Affordability
and treatment burden affect adherence. Reassessment is needed when response or circumstances change.
The specific drug and patient context determine how this principle should be applied in a safe prescribing plan
with attention to individual risk factors, medication history, practical monitoring needs, and timely
reassessment of therapeutic response.
11. An adult develops a persistent dry cough after starting lisinopril. Which class is commonly considered as an
alternative?
A) Another ACE inhibitor at twice the dose
B) Direct thrombin inhibitor
C) Angiotensin receptor blocker
D) Class I antiarrhythmic
Correct Answer: Angiotensin receptor blocker
Rationale: ACE inhibitors can increase bradykinin and provoke cough. ARBs block angiotensin II receptors
without the same bradykinin effect. Prior angioedema requires careful individualized assessment. Treatment
decisions should also reflect comorbidities, current guidelines, and ongoing assessment of clinical response
and adverse effects with attention to individual risk factors, medication history, practical monitoring needs, and
timely reassessment of therapeutic response.
12. For a patient prescribed spironolactone, which laboratory value deserves particular surveillance?
A) Serum amylase alone
B) Platelet count only
C) Serum uric acid only
D) Serum potassium
Correct Answer: Serum potassium
Rationale: Mineralocorticoid receptor antagonists reduce potassium excretion and may cause hyperkalemia.
Renal function also affects risk. Baseline and follow-up monitoring guide safe use. Treatment decisions should
also reflect comorbidities, current guidelines, and ongoing assessment of clinical response and adverse effects
with attention to individual risk factors, medication history, practical monitoring needs, and timely
reassessment of therapeutic response.
13. In symptomatic heart failure with reduced ejection fraction, which drug class has evidence for reducing
hospitalization and mortality?
A) SGLT2 inhibitors
B) Short-acting nitrates alone
